Search
for
Sort by
Research 661–690 of 1000+
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Gynostemma pentaphyllum Hydrodistillate and Its Major Component Damulin B Promote Hair Growth-Inducing Properties In Vivo and In Vitro via the Wnt/β-Catenin Pathway in Dermal Papilla Cells
- Congenital Adrenal Hyperplasia
- Андроген-опосередковані й андрогенонезалежні причини алопеції та акне в жінок. Огляд літератури
- Acne Vulgaris
- Mutations in the vitamin D receptor gene in four patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets
- Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Phytochemistry, pharmacological activity, and potential health benefits of Glycyrrhiza glabra
- A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review
- Treatment of pediatric alopecia areata: A systematic review
- Dupilumab side effect in a patient with atopic dermatitis: a case report study
- Current Biomedical Applications of 3D-Printed Hydrogels
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- A review of environmental and health effects of synthetic cosmetics
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
- A Spontaneous Deletion within the Desmoglein 3 Extracellular Domain of Mice Results in Hypomorphic Protein Expression, Immunodeficiency, and a Wasting Disease Phenotype
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Topical medication instillation techniques for glaucoma
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions